ABSTRACT
OBJECTIVE To investigate the status and effect of influenza vaccination among some elderly population and their cognition of influenza vaccination in Shenzhen Pingshan district, and to provide reference for improving the vaccination willingness of the elderly population. METHODS Descriptive epidemiological method was used to analyze the status quo of influenza vaccination among some elderly populations in Pingshan district; the Logistic regression model was used to analyze the influential factors of influenza vaccination; the serum antibody levels of the elderly population were analyzed before and after influenza vaccination. RESULTS Totally 140 effective survey question naires were collected from elderly. The elderly who participated in the survey had a better cognition of the main transmission mode of the influenza virus, 122 people answered correctly, and the accuracy was 87.1%. Age, knowledge that influenza vaccine should be given once a year and knowledge of Shenzhen’s free vaccination policy were the promoting factors for influenza vaccination behavior among the elderly. The positive rates of the four influenza antibodies (type A H1, type A H3, type B Victoria, type B Yamagata) after inoculation were higher than before inoculation, with statistical significance. The antibody titer levels after vaccination were generally higher than before. CONCLUSIONS The positive rate of antibody testing and antibody titer in the elderly population after influenza vaccination are higher than before, which effectively protects the health of the elderly population. It is necessary to continuously improve the awareness of the elderly population about influenza vaccination and free vaccination policies.
ABSTRACT
Resumen Desde 1982, cada año el Departamento de Inmunizaciones del Ministerio de Salud de Chile lleva a cabo la campaña de vacunación contra influenza junto con las Secretarías Regionales Ministeriales-SEREMI, Servicios de Salud y centros de atención primaria de salud. Con los objetivos de prevenir mortalidad y morbilidad grave en grupos de mayor riesgo y de preservar la integridad de los servicios de salud, hasta el 2020 las campañas de vacunación contra influenza serían las más grandes implementadas en Chile, para dar paso, el 2021, a la vacunación contra SARS-CoV-2. Obedeciendo a cambios demográficos y epidemiológicos locales y acogiendo los avances científicos sobre seguridad e inmunogenicidad de la vacuna, el incremento de las vacunas influenza disponibles en Chile forma parte de la planificación anual de la campaña. El 2020, sin embargo, la Campaña Influenza tuvo que ser re-planificada en curso como consecuencia de la incorporación de nuevos grupos a vacunar según dispuso la modificación de la alerta sanitaria por brote de SARS-CoV-2 del 6 de marzo de 2020. Así, de 6.799.800 de dosis, el Departamento de Inmunizaciones logró en menos de dos meses aumentar la disponibilidad a 8.480.325, y cumplir con el compromiso de garantizar el acceso de los grupos de riesgo al beneficio de la vacunación estatal gratuita.
Abstract In Chile, the Immunization Department of the Ministry of Health has carried out the seasonal influenza vaccination campaign annually since 1982 in collaboration with the national health services, regional health offices, and primary health care centres. With the aim of preventing deaths and serious morbidity in high-risk groups and preserving the integrity of health services, the seasonal influenza campaign had been the largest implemented in Chile until 2020, since in 2021 the vaccination campaign against SARS-CoV-2 is expected to become the largest ever implemented. In response to local demographic and epidemiological changes, and taking into account the new scientific evidence on the safety and immunogenicity of vaccines, the influenza vaccines available in Chile would increase annually as a result of campaign planning. In 2020, the influenza campaign had to be re-planned while in progress due to the addition of new high-risk groups to be vaccinated in accordance with the SARS-CoV-2 pandemic health alert modification of March 6th, 2020. Over the course of three weeks, the Immunization Department managed to increase the doses of available influenza vaccines from 6,799,800 previously agreed upon to 8,480,325 and thus serve high-risk groups, guaranteeing their access to state funded influenza vaccination.
Subject(s)
Humans , Influenza Vaccines , Influenza, Human/prevention & control , Influenza, Human/epidemiology , COVID-19 , Seasons , Chile/epidemiology , Public Health , Mass Vaccination , Immunization Programs , Vaccination Coverage , Pandemics , SARS-CoV-2ABSTRACT
The overall coverage rate of influenza vaccination in China has been only about 2% in recent years. At present, free influenza vaccination programs, also named the "Publicly-funded Influenza Vaccination Project", have been carried out for the specific groups (the elderly, school-age children, healthcare workers, etc.) through livelihood projects or policies to benefit the people in some areas of China, which has significantly increased the vaccine coverage in the target population. In order to promote the project to be launched in a scientific and orderly manner in more and more regions of China, we organized and compiled this consensus on implementation of publicly-funded influenza vaccination project, including the project's purpose, establishment, implementation, organization and management, which was based on the research of influenza vaccine application strategies in some European countries and the United States and combined with the relevant policies, technical guidelines and past experiences in China. Meanwhile, the evaluation indicators, such as vaccination rates, effectiveness, safety and cost-effectiveness, and relevant assessment methods were also comprehensively expounded, aiming to provide reference for regions that are willing to implement or have launched the project.
Subject(s)
Aged , Child , Humans , China , Consensus , Immunization Programs , Influenza Vaccines , Influenza, Human/prevention & control , United States , VaccinationABSTRACT
Abstract INTRODUCTION: The trivalent inactivated influenza vaccine was approved for use in Turkey during the 2018-2019 influenza season. We evaluated beliefs regarding the vaccine and vaccination outcomes in a Turkish population. METHODS: Individuals who were vaccinated with the trivalent inactivated influenza vaccine between November 1 and December 31, 2018, at the Sisli Hamidiye Training and Research Hospital in Istanbul, Turkey, were included in this study. A 15-item questionnaire was completed by a physician during a face-to-face interview with the participants. All participants were followed during the 2018-2019 influenza season through May 2019. The participants were instructed to consult the same physician in case of sudden illness. Participants' beliefs and outcomes were assessed by their vaccination status for the 2017-2018 influenza season. RESULTS: A total of 150 participants were recruited. Their median age was 66 (range, 22-88) years. During the 2017-2018 influenza season, 4.1% had been hospitalized, 53.5% had developed an upper respiratory disease (URD), and 16.2% had been diagnosed with pneumonia. There were no cases of influenza, pneumonia, or hospitalization in the 2019 season; 49.3% of the participants developed a URD (n = 74). Among participants who had been vaccinated during both influenza seasons, 47.5% had had and/or developed a URD, with a higher number of cases during the 2018-2019 season. CONCLUSIONS: After vaccination, no cases of influenza, hospitalization, and pneumonia were observed and the incidence of URD decreased compared with that of the previous season.
Subject(s)
Humans , Male , Female , Adult , Aged , Aged, 80 and over , Young Adult , Influenza Vaccines , Influenza, Human/prevention & control , Seasons , Turkey , Follow-Up Studies , Vaccination , Middle AgedABSTRACT
Resumo A vacina influenza é recomendada para todos trabalhadores de saúde, mas sua cobertura permanece insatisfatória. Estudo transversal que objetivou identificar fatores associados à vacinação contra influenza, realizado com trabalhadores de saúde de um grande Complexo Hospitalar de Salvador, Bahia. Utilizou-se questionário autoaplicável baseado nos modelos "Conhecimento, Atitudes e Práticas" e "Health Belief Model". A variável dependente foi a vacinação contra influenza em 2014, e as independentes representaram fatores sociodemográficos, histórico vacinal, conhecimentos e atitudes sobre influenza/vacina influenza. Usou-se regressão logística, calculou-se odds ratio a intervalos de confiança de 95%, ajustando para sexo, idade e profissão. Elegeu-se o melhor modelo multivariado através de eliminação retrógada e do Critério de Informação de Akaike. Participaram 755 trabalhadores. A cobertura da vacina influenza foi de 61,5%, sendo maior entre enfermeiros (69,0%) e menor entre médicos (49,1%). Os fatores associados a vacinar-se contra influenza foram: conhecer que mesmo estando saudável deve-se vacinar (OR = 3,15; IC95%:1,74-5,71); saber que a vacina não protege por muitos anos (OR = 2,08; IC95%:1,30-3,33); e não temer efeitos adversos pós-vacinais (OR = 1,93; IC95%:1,26-2,95).
Abstract Influenza vaccine is recommended for all health workers, but vaccination coverage remains unsatisfactory. A cross-sectional study that aimed to identify factors associated with influenza vaccination was carried out with health workers from a large Hospital Complex in Salvador, Bahia. A self-administered questionnaire was used based on the models "Knowledge, Attitudes and Practices" and "Health Belief Model". The dependent variable was the vaccination status against influenza in 2014, and the independent variables were sociodemographic factors, vaccine history, knowledge and attitudes about influenza/influenza vaccine. Logistic regression was used, odds ratio was calculated with 95% confidence intervals, adjusting for sex, age and occupation. The best multivariate model was chosen through backwards elimination and the Akaike Information Criterion. 755 workers participated. Influenza vaccine coverage was 61.5%, being higher among nurses (69.0%) and lower among physicians (49.1%). The factors associated with being vaccinated against influenza were: knowing that even when healthy, one must vaccinate against influenza (OR = 3.15; 95%CI:1.74-5.71); knowing that the vaccine does not protect for many years (OR = 2.08; 95%CI:1.30-3.33); and not to be afraid of post-vaccine adverse effects (OR = 1.93; 95%CI: 1.26-2.95).
Subject(s)
Humans , Male , Female , Adult , Young Adult , Influenza Vaccines/administration & dosage , Health Knowledge, Attitudes, Practice , Vaccination/statistics & numerical data , Health Personnel/statistics & numerical data , Influenza, Human/prevention & control , Attitude of Health Personnel , Cross-Sectional Studies , Surveys and Questionnaires , Vaccination Coverage/statistics & numerical data , Middle AgedABSTRACT
Introducción: la vacunación antigripal es la forma más eficaz para prevenir la enfermedad por virus Influenza y sus complicaciones. La cobertura en los profesionales sanitarios es un indicador de calidad hospitalaria. Material y métodos: estudio descriptivo de corte transversal. A partir de registros vacunales, se calculó la cobertura para las campañas 2013 a 2018. Se compararon las coberturas por trienios. Se describieron características generales de las campañas de 2016 a 2018. Resultados: en 2016 se alcanzó la mayor tasa del período (59,79%, IC 95%:58,75-60,81); en 2017, la menor (34,46%, IC 95%:33,48-35,46). La campaña 2018 obtuvo una cobertura de 54,90% (IC 95%: 53,88-55,92) y se inició más tempranamente que otras. Al comparar las tasas trienales del período se observó una diferencia de proporción de -1,3% (IC 95%: -2.84-0.24). Durante los tres últimos años, el personal vacunado correspondió mayormente al sexo femenino, a la Sede Central y tenía relación contractual directa. Las mayores coberturas específicas correspondieron a la sede de San Justo y a los profesionales de enfermería. El puesto ambulante fue el que aplicó más vacunas. Conclusión: si bien hubo variaciones en las coberturas alcanzadas a lo largo de los años, siendo la del año 2016 la más elevada y la del año 2017 la más baja, no se observaron diferencias estadísticamente significativas en las coberturas alcanzadas al comparar trienios. Resulta necesario continuar realizando intervenciones adaptadas al contexto local que permitan alcanzar los objetivos de cobertura esperados. Discusión: se reconocieron varios obstáculos para alcanzar las coberturas esperadas. La educación al personal de salud, la evaluación sistematizada de los ESAVI (Eventos supuestamente atribuibles a vacunación e inmunización) y la descripción de los elementos que facilitaron las coberturas específicas elevadas de algunas subpoblaciones podrían contribuir para mejorar los resultados. (AU)
Introduction: influenza vaccination is the most effective way to prevent influenza virus disease and its complications. Coverage in health professionals measurement is an indicator of hospital quality. Material and methods: descriptive cross-sectional study. From vaccination records, the coverage was calculated for the 2013 to 2018 campaigns. The coverage for three years was compared. General characteristics of the campaigns from 2016 to 2018 were described. Results: in 2016, the highest was achieved during the period (59.79%, IC 95%: 58.75 -60.81). In 2017, the lowest (34.46%, IC 95%: 33.48-35,46). The 2018 campaign achieved a coverage of 54.90% (IC 95%: 53.88-55.92) and started earlier than others. When comparing the triennial rates of the period, a difference of proportion of -1.3% was observed (IC 95%: -2.84-0.24). During the last three years, the vaccinated staff corresponded mostly to the female sex, to the headquarters and had a direct contractual relationship. The largest specific coverage corresponded to the San Justo headquarters and to nursing professionals. The ambulatory position was the post that applied the most vaccines. Conclusion: although there were variations in the coverage achieved over the years, with 2016 being the highest and 2017 being the lowest, there were no statistically significant differences in the coverage achieved when comparing trienniums. It is necessary to continue carrying out interventions adapted to the local context to achieve the expected coverage objectives. Discussion: several obstacles were recognized to reach the expected coverage. The education of health personnel, the systematic evaluation of the ESAVIs and the description of the elements that facilitated the high specific coverage of some subpopulations could contribute to improve the results. (AU)
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Young Adult , Influenza Vaccines/administration & dosage , Orthomyxoviridae Infections/prevention & control , Vaccination Coverage/statistics & numerical data , Quality of Health Care/statistics & numerical data , Influenza Vaccines/adverse effects , Influenza Vaccines/supply & distribution , Sex Factors , Epidemiology, Descriptive , Age Factors , Health Personnel/education , Health Personnel/statistics & numerical data , Immunization Programs/supply & distribution , Immunization Programs/statistics & numerical data , Orthomyxoviridae Infections/complications , Absenteeism , Vaccination Coverage/organization & administrationABSTRACT
ABSTRACT A 19-year-old patient who mistakenly received two doses of influenza vaccine 10 days before presentation, was admitted with malaise, weakness, and a purpuric non-blanching rash most prominent on the ankles followed by abdominal pain and hematochezia 72 h later. The diagnosis of influenza vaccine-related Henoch-Schonlein vasculitis was made. This complication, although rare, is the most common vasculitis related to immunization.
Subject(s)
Humans , Male , Young Adult , IgA Vasculitis/etiology , Influenza Vaccines/adverse effects , IgA Vasculitis/drug therapy , Methylprednisolone/therapeutic use , Prednisone/therapeutic use , Vaccination/adverse effects , Glucocorticoids/therapeutic useABSTRACT
OBJECTIVES: This study aims to identify the coverage rates for influenza vaccination and related factors depending on chronic disease in Korean adults aged 50 and older.METHODS: The 2016 Korea Community Health Survey was used for analysis. Chi-square test was performed to investigate the coverage rates for influenza vaccination depending on chronic disease, and a multiple logistic regression analysis was used to identify the factors associated with influenza vaccination, by chronic disease.RESULTS: In men with ≥1 chronic disease, 39.8% of 50-64 years of age, and 86.8% of elderly (over 65 years of age) received influenza vaccination. In women with ≥1 chronic disease, 58.7% of 50-64 years of age, and 89.9% of elderly (over 65 years of age) received influenza vaccination (p<0.001). The chronic diseases associated with influenza vaccination were hypertension (odds ratio [OR], 1.27; 95% confidence interval [CI], 1.19 to 1.37), diabetes (OR, 1.41; 95% CI, 1.28 to 1.55) in men aged 50-64, hypertension (OR, 1.34; 95% CI, 1.20 to 1.49), diabetes (OR, 1.17; 95% CI, 1.02 to 1.33), chronic cardiovascular disease (OR, 1.31; 95% CI, 1.07 to 1.60) in elderly (over 65 years of age). In women aged 50-64, hypertension (OR, 1.39; 95% CI, 1.30 to 1.49), diabetes (OR, 1.51; 95% CI, 1.35 to 1.68), chronic cardiovascular disease (OR, 1.31; 95% CI, 1.05 to 1.64), and hypertension (OR, 1.55; 95% CI, 1.40 to 1.71), diabetes (OR, 1.27; 95% CI, 1.12 to 1.43) in elderly (over 65 years of age).CONCLUSIONS: Populations in aged 50-64 are recommendation subject for vaccination or classified as high-risk group in case with chronic disease. Though subject over 60 years old is age close to the elderly, the coverage rates for vaccination was low. It is necessary to devise strategies to raise the coverage rates for vaccination.
Subject(s)
Adult , Aged , Female , Humans , Male , Cardiovascular Diseases , Chronic Disease , Health Surveys , Hypertension , Influenza, Human , Korea , Logistic Models , Republic of Korea , VaccinationABSTRACT
OBJECTIVES: This study aims to identify the coverage rates for influenza vaccination and related factors depending on chronic disease in Korean adults aged 50 and older. METHODS: The 2016 Korea Community Health Survey was used for analysis. Chi-square test was performed to investigate the coverage rates for influenza vaccination depending on chronic disease, and a multiple logistic regression analysis was used to identify the factors associated with influenza vaccination, by chronic disease. RESULTS: In men with ≥1 chronic disease, 39.8% of 50-64 years of age, and 86.8% of elderly (over 65 years of age) received influenza vaccination. In women with ≥1 chronic disease, 58.7% of 50-64 years of age, and 89.9% of elderly (over 65 years of age) received influenza vaccination (p<0.001). The chronic diseases associated with influenza vaccination were hypertension (odds ratio [OR], 1.27; 95% confidence interval [CI], 1.19 to 1.37), diabetes (OR, 1.41; 95% CI, 1.28 to 1.55) in men aged 50-64, hypertension (OR, 1.34; 95% CI, 1.20 to 1.49), diabetes (OR, 1.17; 95% CI, 1.02 to 1.33), chronic cardiovascular disease (OR, 1.31; 95% CI, 1.07 to 1.60) in elderly (over 65 years of age). In women aged 50-64, hypertension (OR, 1.39; 95% CI, 1.30 to 1.49), diabetes (OR, 1.51; 95% CI, 1.35 to 1.68), chronic cardiovascular disease (OR, 1.31; 95% CI, 1.05 to 1.64), and hypertension (OR, 1.55; 95% CI, 1.40 to 1.71), diabetes (OR, 1.27; 95% CI, 1.12 to 1.43) in elderly (over 65 years of age). CONCLUSIONS: Populations in aged 50-64 are recommendation subject for vaccination or classified as high-risk group in case with chronic disease. Though subject over 60 years old is age close to the elderly, the coverage rates for vaccination was low. It is necessary to devise strategies to raise the coverage rates for vaccination.
Subject(s)
Adult , Aged , Female , Humans , Male , Cardiovascular Diseases , Chronic Disease , Health Surveys , Hypertension , Influenza, Human , Korea , Logistic Models , Republic of Korea , VaccinationABSTRACT
Here, we describe a case of acute disseminated encephalomyelitis (ADEM) that occurred during a plausible risk interval following inactivated influenza vaccination in a previously healthy 27-year-old man from Manaus, Brazil. He was treated with intravenous methylprednisolone and immunoglobulin. One-month follow-up revealed resolution of the brain lesions, but not of the spinal cord lesions. No recurrence or progression of the main neurological symptoms was observed. After two years of monitoring, the patient continues to experience weak lower limbs and urinary retention. Thus, we recommend that ADEM should be considered in a patient presenting with neurological symptoms after influenza vaccination.
.Subject(s)
Adult , Humans , Male , Encephalomyelitis, Acute Disseminated/etiology , Influenza Vaccines/adverse effects , Encephalomyelitis, Acute Disseminated/diagnosis , Magnetic Resonance ImagingABSTRACT
INTRODUÇÃO: Embora a vacina influenza seja anualmente recomendada para todos trabalhadores de saúde, estudos revelam que a cobertura vacinal desse grupo frequentemente é baixa. Diferentes fatores podem influenciar a vacinação contra a influenza, sendo necessário utilizá-los a favor da ampliação da cobertura vacinal.OBJETIVO: Identificar fatores que influenciam a prática de vacinar-se contra influenza entre trabalhadores de saúde. MATERIAIS E MÉTODOS: estudo transversal, ocorrido num Complexo Hospitalar de Salvador, Bahia. Utilizou-se um questionário autoaplicável, e os modelos "Conhecimento, Atitudes e Práticas" (CAP) e "Health Belief Model" (HBM). A vacinação contra influenza em 2014 (autorreferida)representou a variável principal, e fatores sociodemográficos,histórico de outras vacinas,conhecimentos e atitudes constituíram variáveis independentes.Considerou-se haver "conhecimento adequado", quando 75,0% ou mais dos indivíduos julgaram determinada informação corretamente. As análises foram feitas por regressão logística no Stata, versão 13, utilizando-se o teste qui-quadrado ao nível de 5% de significância, odds ratio, e intervalos de confiança de 95%. O modelo multivariado foi ajustado por sexo, idade e profissão, sendo composto pelas variáveis com p valor igual ou inferior a 0,20 na análise bivariada. A verificação de modelos alternativos mais adequados foi feita por retirada retrógrada, utilizando-se como parâmetro o "Critério de Informação de Akaike" (AIC). RESULTADOS: A amostra foi de 755 indivíduos, destacando-se técnicos de enfermagem (41,4%),enfermeiros (15,2%) e médicos (14,7%).Predominaram trabalhadores do sexo feminino (82,5%), entre 19 e 39 anos (82,4%), com 5 anos ou menos de experiência (67,5%). A cobertura vacinal global foi de 61,5%, sendo a maior entre enfermeiros (69,0%) e a menor entre médicos (49,1%). Os principais motivadores da vacinação foram conhecer a recomendação da vacina para si (49,0%), confiar em vacinas no geral (41,6%) e na eficácia da vacina influenza (35,4%). Os principais desmotivadores foram esquecimento (37,3%), inconveniência de locais/horários (22,5%) e não saber da campanha (16,3%). A principal estratégia que facilitaria a vacinação foi vacinar os trabalhadores no seu próprio setor de trabalho (56,6%). O conhecimento foi adequado no julgamento de 9/16 das informações, com destaque para médicos (15/16) e enfermeiros (13/16). A maior adequação (94,6% de acerto)refere-se à indicação da vacina para todo trabalhador de saúde, e o conhecimento menos adequado foi sobre a incapacidade da vacina causar a influenza (32,0% de acerto). Os fatores associados à vacinação foram: conhecer que pessoas saudáveis também precisam se vacinar contra influenza (OR=3,15 ; IC95%: 1,74 - 5,71); saber que a vacina não protege por muitos anos (OR=2,08 ; IC95%: 1,30 - 3,33); e não ter medo dos efeitos adversos pós-vacinais (OR=1,93 ; IC95%: 1,26 - 2,95). CONCLUSÕES: a vacinação contra influenza é influenciada por onhecimentos,atitudes e questões organizacionais/operacionais.Medidas educativas e de desmistificação de questões relacionadas à influenza e à vacina, bem como ampliação de dias/horários e locais de vacinação de acordo com a conveniência dos trabalhadores de saúde, devem compor as estratégias voltadas à elevação da cobertura da vacina influenza neste grupo.
INTRODUCTION: Although the influenza vaccine is recommended annually for all health workers, studies show that vaccination coverage of this group is often low. Different factors can influence the vaccination against influenza, it is necessary to use them in favor of the expansion of vaccination coverage. GOAL: To identify factors that influence the practice of vaccination against influenza among health workers. MATERIALS AND METHODS: A cross-sectional study, which took place in a hospital complex in Salvador, Bahia. We used a self-administered questionnaire, and the models "Knowledge, Attitudes and Practices"(CAP) and "Health Belief Model"(HBM). Influenza vaccination in 2014 (self-reported) was the main variable, and sociodemographic factors, history of other vaccines, knowledge and attitudes were independent variables. Considered to be "appropriate knowledge" as 75.0% or more of subjects judged certain information correctly. Analyses were performed by logistic regression using Stata, version 13, using the chi-squared test at 5% significance, odds ratio, and 95% confidence intervals. The multivariate model was adjusted for sex, age and profession, being composed of the variables that had a pvalue less than or equal to 0.20 in the bivariate analysis. The verification of most suitable alternative models was performed by backward withdrawal, using as a parameter the "Akaike Information Criteria" (AIC). RESULTS: The sample consisted of 755 individuals, mainly nursing technicians (41.4%), nurses (15.2%) and physicians (14.7%). There was a predominance of female workers (82.5%), between 19 and 39 years (82.4%), with five years or less experience (67.5%). The global vaccination coverage was 61.5%, the highest among nurses (69.0%) and lowest among physicians (49.1%). The main motivators to get vaccinated were to know the recommendation of the vaccine for themselves (49.0%), trust in vaccines in general (41.6%) and in the effectiveness of influenza vaccine (35.4%). The main demotivating were forgetfulness (37.3%), inconvenience locations/times (22.5%) and not knowing the campaign (16.3%). The main strategy would facilitate the vaccination was to inoculate workers in their own work sector (56.6%)...
Subject(s)
Humans , Mass Vaccination/legislation & jurisprudence , Mass Vaccination/methods , Mass Vaccination/organization & administration , Mass Vaccination/statistics & numerical dataABSTRACT
Pseudolymphomas or B‑cell lymphoma at the vaccination site have been reported by several authors. However, onset of cutaneous T‑cell lymphoma with cytotoxic features is a rare complication of vaccination. We report a 27‑year‑old man who developed a nodule and ulcer that arose at the site of injection of influenza vaccine. The neoplastic cells reacted positively for CD56, CD3, CD2, perforin, and granzyme B, but negatively for CD4, CD8, CD10, CD19, CD30, CD34, CD79, and betaF1. Molecular studies showed T‑cell receptor γ (TCR‑γ) chain monoclonal rearrangement. A diagnosis of peripheral T‑cell lymphoma, not otherwise specified (NOS) was established. The patient had high fever, progressive liver dysfunction and a rapid fatal evolution.
Subject(s)
Adult , CD56 Antigen/immunology , Humans , Influenza Vaccines/adverse effects , Lymphoma, T-Cell/etiology , Male , Vaccination/adverse effectsABSTRACT
Con el objetivo de conocer la cobertura y las barreras contra la vacunación antigripal, cuya aceptación estimábamos baja entre el personal de salud(PDS) se realizó un estudio transversal, descriptivo, con la metodología de encuesta, autoadministrada con opciones cerradas para su respuesta. Se utilizó una muestra de 142 PDS integrantes del Hospital Pasteur (MSP-ASSE), aleatorizada y adecuada para extraer conclusiones estadísticamente válidas. Los resultados mostraron que 87/142 (61,3%) de los encuestados conocía la campaña de vacunación antigripal en el Hospital, reconocieron tener indicación de vacunación antigripal 124/142 (87,3%) a pesar de lo cual se vacunaron en 2011 79/142 (55,6%) y en 2012 53/142 (37,3%). Los vacunados en 2012 respondieron como motivos principales de adherencia a la campaña protegerse a sí mismo de la enfermedad, pertenecer al PDS y proteger a su familia. De los no vacunados en 2012 respondieron como motivos principales: percepción de nunca haber contraído gripe, miedo a efectos adversos y descrédito al efecto inmunizador de las vacunas. Se confirmó la baja tasa de vacunación del PDS (37,3% en año 2012) a pesar de reconocer la indicación y tener accesibilidad a la misma; se identificaron como barreras las percepciones erróneas acerca de la vacunación...
Subject(s)
Humans , Health Personnel , Vaccination Coverage , Influenza Vaccines , Mass Vaccination/statistics & numerical data , UruguayABSTRACT
Infection control in the setting of the office based clinic, involves the early detection of disease; disease prevention through vaccination as in influenza and pneumococcal vaccinations; and through screening for asymptomatic disease as in tuberculosis. Family physicians play an important role in these aspects within the community. Although influenza vaccination is effective, the take up rate of vaccination locally is low. Annual vaccination with the current vaccines are strongly recommended in high risk populations such as the elderly, the immunocompromised and, those with co-morbidities. The inactivated trivalent vaccine is the most commonly used. Latent Tuberculosis (TB) Infection is asymptomatic and often goes undetected. Prevention of progression to overt TB can be achieved by identifying high risk persons and the early detection by either the tuberculin skin test or interferon gamma release assays (IGRAs). Invasive pneumococcal disease can lead to significant morbidity and mortality in the young and elderly. In the preventive control of this disease, there are two types of pneumococcal vaccines currently available – the polysaccharide vaccine and the conjugate vaccine. Recommendations for the two different vaccines are in accordance with different at risk populations.
ABSTRACT
Objetivo: Evaluar el impacto de la indicación ministerial de la vacunación contra Influenza a lactantes sanos entre 6 y 24 meses iniciada en el año 2006. Material y método: Revisión retrospectiva de fichas clínicas de pacientes hospitalizados por infección respiratoria causada por virus Influenza entre enero 2004 y diciembre 2007 en el Hospital Roberto del Río. Todos los casos fueron confirmados mediante inmunofluorescencia viral positiva para Influenza A o B. Resultados: De un total de 224 pacientes, 122 corresponden al período prevacuna (años 2004-2005) y 102 al postvacuna (años 2006-2007). La tasa de hospitalización fue similar para todos los años estudiados. Durante el período postvacuna recibieron vacunación solo 4 de los 102 pacientes, el 68 por ciento de los no vacunados se encontraban al momento de la campaña ministerial fuera del rango etario con indicación de vacunación. El 70 por ciento de los hospitalizados corresponden a pacientes menores de 2 años en ambos grupos. No se registró diferencia estadísticamente significativa en sexo, días de hospitalización, requerimientos de oxígeno, ingreso a UCI ni necesidad de ventilación mecánica invasiva. Un 75 por ciento de los hospitalizados corresponde a pacientes sin comorbilidad. Se evidencia un cambio en el patrón estacional de las infecciones por Influenza luego de la introducción de la vacuna manteniéndose éstas presentes a lo largo de todo el año. Conclusiones: No existe una disminución en la tasa de hospitalización ni cambios en las características clínicas de los pacientes hospitalizados luego de la introducción de la vacuna. Si se evidencia un cambio en la distribución estacional con un aplanamiento de la curva a diferencia de la clásica presentación en brote descrita en la literatura y observada en nuestro país previo a esta medida.
Objective: To evaluate the impact of the ministerial statement of vaccination against influenza in healthy infants in the age group of 6 and 24 months since 2006. Material and Methods: Retrospective review of medical records of patients hospitalized due to respiratory infection caused by influenza virus between January 2004 and December 2007 at the Hospital Roberto del Río. All cases were confirmed by positive immunofluorescence for influenza virus A or B. Results: Of a total of 224 patients, 122 are from the pre-vaccination period (2004-2005) and 102 from post vaccination period (2006-2007). The hospitalization rate was similar during the study time course. During the post vaccination period only 4 of 102 patients received vaccination, meanwhile 68 percent of them were out of age requirements for the vaccination ministerial campaign. 70 percent of hospitalized patients are younger than 2 years in both groups. There were not significant differences in sex, hospital stay, oxygen requirements, ICU admission or in the need of invasive mechanical ventilation. 75 percent of hospitalized patients did not exhibit comorbility. These results show a change in the seasonal pattern of influenza infections after the vaccine introduction that remains all over the years. Conclusions: There is not a decrease in the hospitalization rate or a change in the clinical characteristics of hospitalized patients after the vaccine introduction. There is a clear change in the seasonal distribution with a curve flattening, unlike the classic outbreak presentation described in literature and observed in our country prior to this program.
Subject(s)
Humans , Male , Female , Infant , Child, Preschool , Child , Adolescent , Influenza, Human/epidemiology , Influenza, Human/prevention & control , Hospitalization/statistics & numerical data , Influenza Vaccines/administration & dosage , Chile , Age and Sex Distribution , Respiratory Tract Diseases/epidemiology , Respiratory Tract Diseases/therapy , Retrospective Studies , Evaluation of Results of Preventive Actions , Length of Stay , Intensive Care Units/statistics & numerical data , Seasons , Severity of Illness IndexABSTRACT
Bell's palsy, also known as idiopathic facial palsy, is one of the most common causes of peripheral facial nerve palsy. Many studies of the cause and treatment of Bell's palsy have been performed, but the results are still controversial. Clinical cases of other forms of cranial nerve paralysis after influenza vaccination have also been reported. We herein report a review of literature and a case of a 95-year-old female patient who developed left facial paralysis following influenza vaccination.
Subject(s)
Female , Humans , Bell Palsy , Cranial Nerves , Facial Nerve , Facial Paralysis , Influenza, Human , Paralysis , VaccinationABSTRACT
Objective The purpose d this investigation was to evaluate the effect d influenza vaccination among medical staff. Methods We chose 134 medical staff who worked in out-patient department and the wards and received influenza vaccination as the inoculation group, 135 medical staff who did not receive influenza vaccination as the non-inoculation group. Investigation with questionnaires was carried out in the two groups 3 months after vaccination. Results The incidence rate of influenza-like disease in the observation group and the control group was 11.2% and 18.5% respectively. The protective rate was 39.46%. The average illness process of influenza-like disease in the observation group and the control group was 1.73 days and 2.96 days. The percent of patients with no medication, one kind of drug medication and two kinds of drag medication was 46.7%, 33.3% and 20.0% in the observation group and 32.0%, 8.0% and 60.0% in the control group. Conclusion Influenza vaccination exerted protective effect for medical staff and other people at high risk of emergency.
ABSTRACT
Influenza vaccination is recommended for all people over 65 years, for those with chronic respiratory disease and chronic renal failure. Severe side effects of influenza vaccination are rare. We report a case of leukocytoclastic vasculitis in a 68-year-old woman which developed 2 days after influenza vaccination. Disseminated palpable purpura were located on both her lower extremities. A skin biopsy showed characteristic features of leukocytoclastic vasculitis. Purpura were reduced after prednisolone and dapsone medication.
Subject(s)
Aged , Female , Humans , Biopsy , Dapsone , Influenza, Human , Kidney Failure, Chronic , Lower Extremity , Prednisolone , Purpura , Skin , Vaccination , VasculitisABSTRACT
BACKGROUND: Influenza is the representative respiratory infectious disease causing significant high morbidity. Vaccination is the most effective method to prevent influenza. To cope with both unstable supply and increasing demand of influenza vaccine with more flexibility, we studied the safety and immunogenicity of half dose intradermal injection of influenza vaccine in healthy adults compared with full dose intramuscular injection method. MATERIALS AND METHODS: We conducted a randomized, open-label trial in healthy adults of age 15 to 64 years. Subjects were randomly assigned to receive either a recommended dose of influenza vaccine (Fluarix(R), Injection Prefilled Syringe, GlaxoSmithKline, hemagglutinin antigen (HA) 15 microgram) via intramuscular route (designated as control group) or a half recommended dose (HA 7.5 microgram) via intradermal route (designated as experimental group). Blood samplings were done before and more than 28 days after vaccination. We measured the changes in hemagglutination-inhibition (HAI) antibody titers and compared geometric mean titers, seroconversion rates, seroconversion factors and seroprotection rates of each group. Local and systemic adverse events were assessed after vaccination. RESULTS: In antibody titer against all three antigens (A/H1N1, A/H3N2, B) was more evident in intramuscular injection group but intradermal group with half dose showed acceptable immunogenicity fulfilling criteria for Committee for Proprietary Medicinal Products (CPMP). Likewise, seroprotection rates for all three viral strains showed no significant difference between the two groups. Although local reactions were significantly more frequent and lengthy in intradermal group than in intramuscular group, the reactions were mild and transient. CONCLUSION: Compared with intramuscular injection of full dose influenza vaccine, intradermal injection of half dose resulted in comparable immunogenicity in healthy adults. Intradermal administration of half dose influenza vaccine could be a practical alternative plan to expand the supplies of influenza vaccine, but further studies will be needed in high risk groups.
Subject(s)
Adult , Humans , Communicable Diseases , Equipment and Supplies , Hemagglutinins , Influenza Vaccines , Influenza, Human , Injections, Intradermal , Injections, Intramuscular , Pliability , Syringes , VaccinationABSTRACT
BACKGROUND: Influenza is the representative respiratory infectious disease causing significant high morbidity. Vaccination is the most effective method to prevent influenza. To cope with both unstable supply and increasing demand of influenza vaccine with more flexibility, we studied the safety and immunogenicity of half dose intradermal injection of influenza vaccine in healthy adults compared with full dose intramuscular injection method. MATERIALS AND METHODS: We conducted a randomized, open-label trial in healthy adults of age 15 to 64 years. Subjects were randomly assigned to receive either a recommended dose of influenza vaccine (Fluarix(R), Injection Prefilled Syringe, GlaxoSmithKline, hemagglutinin antigen (HA) 15 microgram) via intramuscular route (designated as control group) or a half recommended dose (HA 7.5 microgram) via intradermal route (designated as experimental group). Blood samplings were done before and more than 28 days after vaccination. We measured the changes in hemagglutination-inhibition (HAI) antibody titers and compared geometric mean titers, seroconversion rates, seroconversion factors and seroprotection rates of each group. Local and systemic adverse events were assessed after vaccination. RESULTS: In antibody titer against all three antigens (A/H1N1, A/H3N2, B) was more evident in intramuscular injection group but intradermal group with half dose showed acceptable immunogenicity fulfilling criteria for Committee for Proprietary Medicinal Products (CPMP). Likewise, seroprotection rates for all three viral strains showed no significant difference between the two groups. Although local reactions were significantly more frequent and lengthy in intradermal group than in intramuscular group, the reactions were mild and transient. CONCLUSION: Compared with intramuscular injection of full dose influenza vaccine, intradermal injection of half dose resulted in comparable immunogenicity in healthy adults. Intradermal administration of half dose influenza vaccine could be a practical alternative plan to expand the supplies of influenza vaccine, but further studies will be needed in high risk groups.